Interleukin-6 in Aging and Chronic Disease: A Magnificent Pathway
Open accessThe DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Abstract
The human interleukin IL-6 was originally cloned in 1986. In 1993, William Ershler, in his article "IL-6: A Cytokine for Gerontologists," indicated IL-6 as one of the main signaling pathways modulating the complex relationship between aging and chronic morbidity. Over the last 12 years, our understanding of the role of IL-6 in human physiology and pathology has substantially grown, although some of the questions originally posed by Ershler are still debated. In this review, we will focus on IL-6 structure, IL-6 signaling, and trans signaling pathways, and the role of IL-6 in geriatric syndromes and chronic disease. In the final section of this review, we dissect the critical elements of the IL-6 signaling pathway and point out targets for intervention that are targeted by emerging drugs, some still on the horizon and others already being tested in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 1×
“Other typical manifestations of acute inflammation, such as fever, activation of the hypothalamic–pituitary–adrenal axis, anorexia, and lethargy are similarly induced by IL-6 (34).”
BackgroundC-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
The anti-inflammatory effect of exercise
Petersen, A. M. W., & Pedersen, B. K. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00164.2004 · Cited by 3,100 · cited 1×
“It has been suggested that IL-6 is important for the process of muscle repair and cell turnover, as well as for some of the beneficial health effects of exercise, especially on lipids (63).”
BackgroundInterleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 1×
“Recent preclinical studies suggest that IL-6 stimulates hepatocytes to produce hepcidin, a polypeptide that inhibits intestinal absorption and reticuloendothelial release of iron (124).”
BackgroundSoulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M., Clauvel, J., Raphael, M., Degos, L., et al. (1995) · Blood · doi:10.1182/blood.v86.4.1276.bloodjournal8641276 · Cited by 2,157
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139 · cited 2×
“STRUCTURE AND SIGNALING PATHWAYS OF IL-6: A WONDERFUL COMPLEXITY IL-6 is a helical glycoprotein with a molecular weight from 20 to 30 kD (1).”
BackgroundInterleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,012
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,668
Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,528
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Self-citationInterleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
Ershler, W. B., & Keller, E. T. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.245 · Cited by 1,282
Interleukin-6 family of cytokines and gp130
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,272
Fried, S. K. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.847 · Cited by 1,145
IL-6 is produced by osteoblasts and induces bone resorption.
Ishimi, Y., Miyaura, C., Jin, C. H., Akatsu, T., Abe, E., Nakamura, Y., Yamaguchi, A., Yoshiki, S., Matsuda, T., Hirano, T., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3297 · Cited by 1,128
Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., & Kishimoto, T. (1988) · Science · doi:10.1126/science.3136546 · Cited by 1,060
Molecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
INTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology
Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,024
Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v75.1.40.40 · Cited by 1,012
Changes in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
The origins of age-related proinflammatory state
Ferrucci, L., Corsi, A., Lauretani, F., Bandinelli, S., Bartali, B., Taub, D. D., Guralnik, J. M., & Longo, D. L. (2005) · Blood · doi:10.1182/blood-2004-07-2599 · Cited by 908
Self-citationInflammatory Markers and Physical Performance in Older Persons: The InCHIANTI Study
Cesari, M., Penninx, B. W. J. H., Pahor, M., Lauretani, F., Corsi, A. M., Williams, G. R., Guralnik, J. M., & Ferrucci, L. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.m242 · Cited by 901
Self-citationHoussiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
Tilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
Serum IL‐6 Level and the Development of Disability in Older Persons
Ferrucci, L., Harris, T. B., Guralnik, J. M., Tracy, R. P., Corti, M., Cohen, H. J., Penninx, B., Pahor, M., Wallace, R., & Havlik, R. J. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb01583.x · Cited by 809
Self-citationInflammatory Markers and Risk of Developing Type 2 Diabetes in Women
Hu, F. B., Meigs, J. B., Li, T. Y., Rifai, N., & Manson, J. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.693 · Cited by 788
Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., & Kishimoto, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20303 · Cited by 788
Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-6
Jones, S. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3463 · Cited by 771
Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease
Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4602 · Cited by 754
Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031069 · Cited by 731
Traenckner, E. B., Wilk, S., & Baeuerle, P. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06878.x · Cited by 710
Blaskovich, M. A., Sun, J., Cantor, A. B., Turkson, J., Jove, R., & Sebti, S. M. (2003) · PubMed · Cited by 643
Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., & FULLER, G. M. (2001) · The FASEB Journal · doi:10.1096/fj.99-1003rev · Cited by 623
Senn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., & Mooney, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210689200 · Cited by 620
IL-6-induced skeletal muscle atrophy
Haddad, F., Zaldivar, F., Cooper, D. M., & Adams, G. R. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01026.2004 · Cited by 612
Nakajima, T., Kinoshita, S., Sasagawa, T., Sasaki, K., Naruto, M., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2207 · Cited by 578
Nappo, F., Esposito, K., Cioffi, M., Giugliano, G., Molinari, A. M., Paolisso, G., Marfella, R., & Giugliano, D. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01741-2 · Cited by 555
Kotake, S., Sato, K., Kim, K. J., Takahashi, N., Udagawa, N., Nakamura, I., Yamaguchi, A., Kishimoto, T., Suda, T., & Kashiwazaki, S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110113 · Cited by 545
Kristiansen, O. P., & Mandrup-Poulsen, T. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s114 · Cited by 524
Interleukin-6 in human multiple myeloma
Klein, B., Zhang, X., Lu, Z., & Bataille, R. (1995) · Blood · doi:10.1182/blood.v85.4.863.bloodjournal854863 · Cited by 520
Bharti, A. C., Donato, N., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3863 · Cited by 508
The soluble interleukin‐6 receptor is generated by shedding
Mülberg, J., Schooltink, H., Stoyan, T., Günther, M., Graeve, L., Buse, G., Mackiewicz, A., Heinrich, P. C., & Rose‐John, S. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230226 · Cited by 506
Trikha, M., Corringham, R. E., Klein, B., & Rossi, J. (2003) · PubMed · Cited by 506
The Association of Plasma IL-6 Levels With Functional Disability in Community-Dwelling Elderly
Cohen, H. J., Pieper, C. F., Harris, T., Rao, K. M. K., & Currie, M. S. (1997) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/52a.4.m201 · Cited by 476
Cis3/Socs3/Ssi3 Plays a Negative Regulatory Role in Stat3 Activation and Intestinal Inflammation
Suzuki, A., Hanada, T., Mitsuyama, K., Yoshida, T., Kamizono, S., Hoshino, T., Kubo, M., Yamashita, A., Okabe, M., Takeda, K., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.471 · Cited by 471
Interleukin‐6: A Cytokine for Gerontolgists
Ershler, W. B. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb02054.x · Cited by 469
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T., & Yoshizaki, K. (2000) · Blood · doi:10.1182/blood.v95.1.56 · Cited by 441
Taaffe, D. R., Harris, T. B., Ferrucci, L., Rowe, J., & Seeman, T. E. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.12.m709 · Cited by 438 · cited 1×
“Elevated serum IL-6 is positively associated with markers of physical frailty such as low walking speed, poor muscle strength (94), poor lower extremity performance (95), and anemia (96), even after adjustment for confounders.”
BackgroundSelf-citationBellido, T., Jilka, R. L., Boyce, B. F., Girasole, G., Broxmeyer, H., Dalrymple, S. A., Murray, R., & Manolagas, S. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117995 · Cited by 430
Bruun, J. M., Helge, J. W., Richelsen, B., & Stallknecht, B. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00506.2005 · Cited by 429
Udagawa, N., Takahashi, N., Katagiri, T., Tamura, T., Wada, S., Findlay, D. M., Martin, T. J., Hirota, H., Taga, T., Kishimoto, T., et al. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1461 · Cited by 409
Increase of plasma IL-6 concentration with age in healthy subjects
Wei, J., Xu, H., Davies, J. L., & Hemmings, G. P. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90112-3 · Cited by 402
Matthews, V., Schuster, B., Schütze, S., Bussmeyer, I., Ludwig, A., Hundhausen, C., Sadowski, T., Saftig, P., Hartmann, D., Kallen, K.-J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210584200 · Cited by 390 · cited 1×
“The shedding process is stimulated by several factors including C-reactive protein (20) (which through this mechanism amplifies the IL-6 signaling), IL-8 (21), and cellular cholesterol depletion (22), and blocked by a metalloprotease inhibitor and tumor necrosis factor (TNF)-alpha protease inhibitor (TAPI) (23).”
BackgroundLeng, S., Chaves, P., Koenig, K., & Walston, J. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50315.x · Cited by 387
Bone marrow, cytokines, and bone remodeling
Manolagas, S. C. (1995) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(96)82696-5 · Cited by 387
Molecular mechanisms of aging-associated inflammation
Sarkar, D., & Fisher, P. B. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.04.009 · Cited by 359
Straub, R. H., Konecná, L., Hrach, S., Rothe, G., Kreutz, M. P., Schölmerich, J., Falk, W., & Lang, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.2012 · Cited by 353
Induction of Interleukin 6 (IL-6) by Hypoxia in Vascular Cells
Yan, S. F., Tritto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G., Brett, J., May, L., & Stern, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11463 · Cited by 345
Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G., Taga, T., & Kishimoto, T. (1993) · Blood · doi:10.1182/blood.v82.4.1120.1120 · Cited by 343
Madhok, R., Crilly, A., Watson, J., & Capell, H. A. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.3.232 · Cited by 340
IL-6 and its circadian secretion in humans
Vgontzas, A. N., Bixler, E. O., Lin, H.-M., Prolo, P., Trakada, G., & Chrousos, G. P. (2005) · Neuroimmunomodulation · doi:10.1159/000084844 · Cited by 338
(1993) · PubMed · Cited by 330
Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons
Barbieri, M., Ferrucci, L., Ragno, E., Corsi, A., Bandinelli, S., Bonafè, M., Olivieri, F., Giovagnetti, S., Franceschi, C., Guralnik, J. M., et al. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00319.2002 · Cited by 304
Self-citationHata, H., Sakaguchi, N., Yoshitomi, H., Iwakura, Y., Sekikawa, K., Azuma, Y., Kanai, C., Moriizumi, E., Nomura, T., Nakamura, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421795 · Cited by 304
Rationale for interleukin-6 blockade in systemic lupus erythematosus
Tackey, E., Lipsky, P. E., & Illei, G. G. (2004) · Lupus · doi:10.1191/0961203304lu1023oa · Cited by 303
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease
Gross, V., Andus, T., Caesar, I., Roth, M., & Schölmerich, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90098-j · Cited by 293
Role of the proteasome and NF-κB in streptococcal cell wall-induced polyarthritis
Palombella, V. J., Conner, E. M., Fuseler, J. W., Destree, A., Davis, J. M., Laroux, F. S., Wolf, R. E., Huang, J., Brand, S., Elliott, P. J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15671 · Cited by 287
Cappola, A. R., Xue, Q.-L., Ferrucci, L., Guralnik, J. M., Volpato, S., & Fried, L. P. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021694 · Cited by 286 · cited 2×
“Interestingly, low IGF-1 and IL-6 levels were independent and almost synergistic risk factors for disability both in the Women’s Health and Aging Study I and in the InCHIANTI Study (99,100).”
BackgroundSelf-citationSaito, M., Yoshida, K., Hibi, M., Taga, T., & Kishimoto, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.12.4066 · Cited by 282
Leng, S. X., Cappola, A. R., Andersen, R. E., Blackman, M. R., Koenig, K., Blair, M., & Walston, J. D. (2004) · Aging Clinical and Experimental Research · doi:10.1007/bf03324545 · Cited by 270 · cited 1×
“Frail study participants have higher levels of IL-6 than nonfrail, age-matched individuals (93).”
BackgroundNowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S., & Jones, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3202 · Cited by 268
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity
Sun, J., Blaskovich, M. A., Jove, R., Livingston, S. K., Coppola, D., & Sebti, S. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208470 · Cited by 263
Sex Hormones Modulate Inflammatory Mediators Produced by Macrophages a
D'AGOSTINO, P., MILANO, S., BARBERA, C., DI BELLA, G., LA ROSA, M., FERLAZZO, V., FARRUGGIO, R., MICELI, D. M., MIELE, M., CASTAGNETTA, L., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07667.x · Cited by 262
Shariat, S. F., Andrews, B., Kattan, M. W., Kim, J., Wheeler, T. M., & Slawin, K. M. (2001) · Urology · doi:10.1016/s0090-4295(01)01405-4 · Cited by 261
Jones, S. A., & Rose-John, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00319-1 · Cited by 255
Review: IL-6 Transsignaling: The In Vivo Consequences
Jones, S. A., Richards, P. J., Scheller, J., & Rose-John, S. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.241 · Cited by 251
A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor
Müllberg, J., Durie, F. H., Otten-Evans, C., Alderson, M. R., Rose-John, S., Cosman, D., Black, R. A., & Mohler, K. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.11.5198 · Cited by 249
THE PROTEASOME AND PROTEASOME INHIBITORS IN CANCER THERAPY
Voorhees, P. M., & Orlowski, R. Z. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141300 · Cited by 247
Arnaud, C., Burger, F., Steffens, S., Veillard, N. R., Nguyen, T. H., Trono, D., & Mach, F. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000163840.63685.0c · Cited by 247
Cytokines in Neuroinflammation and Alzheimers Disease
Cacquevel, M., Lebeurrier, N., Cheenne, S., & Vivien, D. (2004) · Current Drug Targets · doi:10.2174/1389450043345308 · Cited by 245
Proinflammatory state and circulating erythropoietin in persons with and without anemia
Ferrucci, L., Guralnik, J. M., Woodman, R. C., Bandinelli, S., Lauretani, F., Corsi, A. M., Chaves, P. H. M., Ershler, W. B., & Longo, D. L. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.039 · Cited by 240 · cited 1×
“Moreover, consuming a Mediterranean diet is associated with significantly lower IL-6 (61,62).”
BackgroundSelf-citationInterleukin 6 Supports the Maintenance of p53 Tumor Suppressor Gene Promoter Methylation
Hodge, D. R., Peng, B., Cherry, J. C., Hurt, E. M., Fox, S. D., Kelley, J. A., Munroe, D. J., & Farrar, W. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3589 · Cited by 226
Inflammatory markers and cardiovascular health in older adults
KRITCHEVSKY, S., CESARI, M., & PAHOR, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.026 · Cited by 222
Association of IGF-I levels with muscle strength and mobility in older women
Cappola, A. R., Bandeen-Roche, K., Wand, G. S., Volpato, S., & Fried, L. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7868 · Cited by 205
The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases
Kallen, K.-J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00325-7 · Cited by 205
Maggio, M., Basaria, S., Ble, A., Lauretani, F., Bandinelli, S., Ceda, G. P., Valenti, G., Ling, S. M., & Ferrucci, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1097 · Cited by 200 · cited 1×
“In male participants of the InCHIANTI study population living in Tuscany (Italy), we found a significant, inverse independent association of bioavailable and total testosterone with sIL-6r, but not IL-6 and other inflammatory markers (85).”
BackgroundSelf-citationProtective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model
Barton, B. E., & Jackson, J. V. (1993) · Infection and Immunity · doi:10.1128/iai.61.4.1496-1499.1993 · Cited by 200
C-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding
Jones, S. A., Novick, D., Horiuchi, S., Yamamoto, N., Szalai, A. J., & Fuller, G. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.599 · Cited by 196
Khosla, S., Atkinson, E. J., Dunstan, C. R., & O’Fallon, W. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8397 · Cited by 191 · cited 1×
“Similarly, Khosla and coauthors found that antiandrogen treatment in men increased IL-6 and sIL-6r levels, and testosterone partially reverses this effect (86).”
BackgroundAdvances in the anemia of chronic disease.
Means, R. T. (1999) · PubMed · Cited by 191
Cytokine-Related Aging Process
Morley, J. E., & Baumgartner, R. N. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.9.m924 · Cited by 188
Mitsuyama, K., Toyonaga, A., Sasaki, E., Ishida, O., Ikeda, H., Tsuruta, O., Harada, K., Tateishi, H., Nishiyama, T., & Tanikawa, K. (1995) · Gut · doi:10.1136/gut.36.1.45 · Cited by 186
Klouche, M., Bhakdi, S., Hemmes, M., & Rose-John, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4583 · Cited by 178
Hirano, T., Matsuda, T., & Nakajima, K. (1994) · STEM CELLS · doi:10.1002/stem.5530120303 · Cited by 176
gp130 CYTOKINE FAMILY AND BONE CELLS
Heymann, D., & Rousselle, A.-V. (2000) · Cytokine · doi:10.1006/cyto.2000.0747 · Cited by 173
Interleukin-6 and selected plasma proteins in healthy persons of different ages
Hager, K., Machein, U., Krieger, S., Platt, D., Seefried, G., & Bauer, J. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90066-3 · Cited by 172
Elosua, R., Bartali, B., Ordovas, J. M., Corsi, A. M., Lauretani, F., Ferrucci, L., & on Behalf of the InCHIANTI Investigators (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.6.760 · Cited by 171
Self-citationWang, L. H., Kirken, R. A., Erwin, R. A., Yu, C.-R., & Farrar, W. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3897 · Cited by 161
Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6
Miyaura, C., Kusano, K., Masuzawa, T., Chaki, O., Onoe, Y., Aoyagi, M., Sasaki, T., Tamura, T., Koishihara, Y., Ohsugi, Y., et al. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100914 · Cited by 160
Keller, E. T., Chang, C., & Ershler, W. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26267 · Cited by 152
Giuliani, N., Sansoni, P., Girasole, G., Vescovini, R., Passeri, G., Passeri, M., & Pedrazzoni, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00220-5 · Cited by 151 · cited 2×
“However, human studies show that IL-6 and sIL-6r levels are negatively associated with bone mineral density, and the IL-6 gene is an independent predictor of bone mineral density and peak bone mass (53,72,73).”
BackgroundReinisch, W., Gasché, C., Tillinger, W., Wyatt, J., Lichtenberger, C., Willheim, M., Dejaco, C., Waldhör, T., Bakos, S., Vogelsang, H., et al. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01288.x · Cited by 150
Brocke-Heidrich, K., Kretzschmar, A. K., Pfeifer, G., Henze, C., Löffler, D., Koczan, D., Thiesen, H.-J., Burger, R., Gramatzki, M., & Horn, F. (2004) · Blood · doi:10.1182/blood-2003-04-1048 · Cited by 150
Schooley, J. C., Kullgren, B., & Allison, A. C. (1987) · British Journal of Haematology · doi:10.1111/j.1365-2141.1987.00011.x · Cited by 148
Nagel‐Wolfrum, K., Buerger, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.170.2.3 · Cited by 146
Weigert, C., Hennige, A. M., Lehmann, R., Brodbeck, K., Baumgartner, F., Schaüble, M., Häring, H. U., & Schleicher, E. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509782200 · Cited by 141
Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges, A., Gabay, C., Silacci, P., Novick, D., Roux-Lombard, P., Grau, G. E., Dayer, J. M., VISCHER, T. L., & Guerne, P. A. (1997) · PubMed · Cited by 134
Bauer, J., Bauer, T. M., Kalb, T., Taga, T., Lengyel, G., Hirano, T., Kishimoto, T., Acs, G., Mayer, L., & Gerok, W. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.5.1537 · Cited by 131
Choi, S.-E., Choi, K.-M., Yoon, I., Shin, J., Kim, J.-S., Park, W., Han, D. J., Kim, S.-C., Ahn, C., Kim, J., et al. (2004) · Transplant Immunology · doi:10.1016/j.trim.2004.04.001 · Cited by 130
Hypoxemia increases serum interleukin-6 in humans
Klausen, T. L., Olsen, N. V., Poulsen, T. D., Richalet, J., & Pedersen, B. K. (1997) · European Journal of Applied Physiology · doi:10.1007/s004210050278 · Cited by 129
Role of Cytokines in the Pathogenesis of Autoimmune Diabetes Mellitus
Rabinovitch, A., & Suarez‐Pinzon, W. L. (2003) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1025160614313 · Cited by 120
Abbatecola, A. M., Ferrucci, L., Grella, R., Bandinelli, S., Bonafè, M., Barbieri, M., Corsi, A. M., Lauretani, F., Franceschi, C., & Paolisso, G. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52112.x · Cited by 116
Self-citationRose‐John, S., & Neurath, M. F. (2004) · Immunity · doi:10.1016/s1074-7613(04)00003-2 · Cited by 115
Weigert, C., Hennige, A. M., Brodbeck, K., Häring, H. U., & Schleicher, E. D. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00448.2004 · Cited by 113
Baraldi-Junkins, C. A., Beck, A. C., & Rothstein, G. (2000) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70277-x · Cited by 109
IL-6 Type Cytokine Receptor Complexes: Hexamer, Tetramer or Both?
Grötzinger, J., Kernebeck, T., Kallen, K.-J., & Rose-John, S. (1999) · Biological Chemistry · doi:10.1515/bc.1999.100 · Cited by 107
Bone Marrow Erythropoiesis in the Anemia of Infection, Inflammation, and Malignancy
Zucker, S., Friedman, S., & Lysik, R. M. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107651 · Cited by 107
Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women
Mckane, W. R., Khosla, S., Peterson, J. M., Egan, K., & Riggs, B. L. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090821 · Cited by 105
The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody
Mihara, M., Nishimoto, N., & Ohsugi, Y. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.5.683 · Cited by 98
Elevated Plasma Levels of Interleukin‐6 in Postmenopausal Women Do Not Correlate with Bone Density
Kania, D. M., Binkley, N., Checovich, M., Havighurst, T., Schilling, M., & Ershler, W. B. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb07328.x · Cited by 97
Sporeno, E., Savino, R., Ciapponi, L., Paonessa, G., Cabibbo, A., Lahm, A., Pulkki, K., Sun, R., Toniatti, C., & Klein, B. (1996) · Blood · doi:10.1182/blood.v87.11.4510.bloodjournal87114510 · Cited by 90
Soluble interleukin‐6 receptor as a prognostic factor in multiple myeloma
Pulkki, K., Pelliniemi, T., Rajamäki, A., Tienhaara, A., Laakso, M., & Lahtinen, R. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1470.x · Cited by 88
Ferrari, S., Karasik, D., Liu, J., Karamohamed, S., Herbert, A. G., Cupples, L. A., & Kiel, D. P. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040103 · Cited by 83
Barton, B. E. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.737 · Cited by 80
Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells
Gouill, S. L., Pellat‐Deceunynck, C., Harousseau, J., Rapp, M., Robillard, N., Bataille, R., & Amiot, M. (2002) · Leukemia · doi:10.1038/sj.leu.2402629 · Cited by 80
Estrogen loss upregulates hematopoiesis in the mouse: a mediating role of IL-6.
Jilka, R. L., Passeri, G., Girasole, G., Cooper, S. H., Abrams, J. S., Broxmeyer, H. E., & Manolagas, S. C. (1995) · PubMed · Cited by 80
März, P., Heese, K., Höck, C., Golombowski, S., Müller-Spahn, F., Rose‐John, S., & Otten, U. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00886-0 · Cited by 79
Soluble interleukin‐6 receptor (sIL‐6R), a new prognostic factor in multiple myeloma
KYRTSONIS, M., DEDOUSSIS, G., ZERVAS, C., PERIFANIS, V., BAXEVANIS, C., STAMATELOU, M., & MANIATIS, A. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.4721018.x · Cited by 79
Hofbauer, L. C., Ten, R. M., & Khosla, S. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.8.1330 · Cited by 77
Walston, J. D., Arking, D. E., Fallin, M. D., Li, T., Beamer, B. A., Xue, Q., Ferrucci, L., Fried, L. P., & Chakravarti, A. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.01.012 · Cited by 70
Self-citationDavid, E., Sun, S., Waller, E. K., Chen, J., Khuri, F. R., & Lonial, S. (2005) · Blood · doi:10.1182/blood-2005-06-2584 · Cited by 66
Moffett, S. P., Zmuda, J. M., Cauley, J. A., Stone, K. L., Nevitt, M. C., Ensrud, K. E., Hillier, T. A., Hochberg, M., Joslyn, G., Morin, P. A., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040707 · Cited by 59
Iwasaki, Y., Asai, M., Yoshida, M., Nigawara, T., Kambayashi, M., & Nakashima, N. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031441 · Cited by 58
Marin, V., Montero-Julian, F., Grès, S., Bongrand, P., Farnarier, C., & Kaplanski, G. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(2002010)32:10<2965::aid-immu2965>3.0.co;2-v · Cited by 58
Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease
Hampel, H. J., Sunderland, T., Kötter, H. U., Schneider, C., Teipel, S. J., Padberg, F., Dukoff, R. A., Levy, J., & Möller, H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01355-3 · Cited by 57
Lambert, C. P., Sullivan, D. H., & Evans, W. J. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.2.m165 · Cited by 57
Prestwood, K. M., Unson, C., Kulldorff, M., & Cushman, M. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.8.m827 · Cited by 57
The soluble IL-6 receptors: serum levels and biological function.
Fa, M.-J. (2001) · PubMed · Cited by 57
Forsblad‐d’Elia, H., Mattsson, L., Ohlsson, C., Nordborg, E., & Carlsten, H. (2003) · Arthritis Research & Therapy · doi:10.1186/ar761 · Cited by 54
Wadt, K. A., Larsen, C. M., Andersen, H. U., Nielsen, K., Karlsen, A. E., & Mandrup-Poulsen, T. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1602 · Cited by 50
Cytokine Changes in Postmenopausal Women Treated with Estrogens: a Placebo‐controlled Study
BERG, G., EKERFELT, C., HAMMAR, M., LINDGREN, R., MATTHIESEN, L., & ERNERUDH, J. (2002) · American Journal of Reproductive Immunology · doi:10.1034/j.1600-0897.2002.01061.x · Cited by 48
Girasole, G., Giuliani, N., Modena, A. B., Passeri, G., & Pedrazzoni, M. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00896.x · Cited by 46
Koh, S. I., Masayuki, T., José, S., Yasuo, K., Ohsugi, Y., Kishimoto, T., & Bendig, M. M. (1994) · Molecular Immunology · doi:10.1016/0161-5890(94)90115-5 · Cited by 46
Pacifici, R. (1999) · Calcified Tissue International · doi:10.1007/s002239900710 · Cited by 44
Perspectives for combination therapy to overcome drug-resistant multiple myeloma
Catley, L. P., Tai, Y., CHAUHAN, D., & Anderson, K. C. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.06.001 · Cited by 44
Demonstration of a TH1cytokine profile in the late phase of NOD insulitis
Pilström, B., Björk, L., & Böhme, J. (1995) · Cytokine · doi:10.1006/cyto.1995.0097 · Cited by 40
Holub, M., Makó, E., Dévay, T., Dank, M., Szalai, C., Fenyvesi, A., & Falus, A. (1998) · PubMed · Cited by 35
Mitsuyama, K., Tomiyasu, N., Suzuki, A., Takaki, K., Takedatsu, H., Masuda, J., Yamasaki, H., Matsumoto, S., Tsuruta, O., Toyonaga, A., et al. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02960.x · Cited by 34
Guler, N., Batyraliev, T., Dulger, H., Ozkara, C., Tuncer, M., Aslan, S., Okut, H., & Agirbasli, M. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.06.027 · Cited by 33
Carey, J. R., Robine, J., Michel, J. P., & Christen, Y. (2005) · Springer eBooks · doi:10.1007/b138997 · Cited by 33
Kyriakou (1997) · International Journal of Hematology · doi:10.1016/s0925-5710(97)00055-8 · Cited by 28
Kopantzev, Y., Heller, M., Swaminathan, N., & Rudikoff, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205815 · Cited by 25
Bertolini, D. R., Votta, B. J., Hoffman, S. J., & Strassmann, G. (1994) · Cytokine · doi:10.1016/1043-4666(94)90060-4 · Cited by 17
Petrucci, M. T., Ricciardi, M. R., Ariola, C., Gregorj, C., Ribersani, M., Savino, R., Ciliberto, G., & Tafuri, A. (1999) · Annals of Hematology · doi:10.1007/s002770050465 · Cited by 17
Gleason, E. L., Hogan, J. C., & Stephens, J. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.081 · Cited by 13
Inflammation: The Fire of Frailty?
Ferrucci, L., Blè, A., Bandinelli, S., Windham, B. G., & Simonsick, E. M. (2005) · Springer eBooks · doi:10.1007/3-540-27388-3_8 · Cited by 9
Self-citation
Cited by
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Franceschi, C., & Campisi, J. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu057 · Cited by 3,891
Inflammatory networks during cellular senescence: causes and consequences.
Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.003 · Cited by 1,354
Daynes, R. A., Araneo, B. A., Ershler, W. B., Maloney, C., Li, G. Z., & Ryu, S. Y. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5219 · Cited by 1,264
Aging in COVID-19: Vulnerability, immunity and intervention
Chen, Y., Klein, S. L., Garibaldi, B. T., Li, H., Wu, C., Osevala, N. M., Li, T., Margolick, J. B., Pawelec, G., & Leng, S. X. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101205 · Cited by 1,007
How the ageing microenvironment influences tumour progression
Fane, M., & Weeraratna, A. T. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0222-9 · Cited by 849
Metadata
- Authors
- Maggio, M., Guralnik, J. M., Longo, D. L., & Ferrucci, L.
- Venue
- The Journals of Gerontology: Series A
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-06-01
- Volume
- 61
- Issue
- 6
- Pages
- 575-584
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- OpenAlex
- W2098930053
- Cited by
- 692
- References
- 165
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.